Browse studies
Find your next paid study
4 recruiting studies matching your filters
Phase 2
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of NTX-1472, a V1a Receptor Antagonist, in Adults With Social Anxiety Disorder
The primary goal of this Phase 2 clinical trial is to determine the effects of a novel V1a receptor antagonist (NTX-1472) in adults with Social Anxiety Disorde…
Social Anxiety Disorder (SAD)
Newleos Therapeutics, Inc.NCT07323784
Phase 3
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Acute Anxiety in Patients With Social Anxiety Disorder
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to plac…
Social Anxiety Disorder (SAD)
Vanda PharmaceuticalsNCT07221578
Observational
Stepped Care Cognitive Behavioral Therapy for Children and Adolescents With Anxiety
Childhood anxiety disorders (CAD) are common and impairing. Family based cognitive behavioral therapy (CBT) is efficacious in treating CAD. Yet, many children …
Generalized Anxiety Disorder (GAD)Social Anxiety Disorder (SAD)Separation Anxiety Disorder+3 more
Andrew WieseNCT07228143
Phase 3
US, Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Clinical Trial of Fasedienol Nasal Spray for the Acute Treatment of Anxiety Induced by a Public Speaking Challenge in Adult Subjects With Social Anxiety Disorder, With an Open-Label Extension (PALISADE-4)
This U.S. Phase 3 clinical trial is designed to evaluate the efficacy, safety, and tolerability of the acute intranasal (i.n.) administration of Fasedienol Nas…
Social Anxiety Disorder (SAD)
VistaGen Therapeutics, Inc.NCT06615557